Strides Pharma Science share news and announcements
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Formerly Strides Shasun
Last close ₹1,014.80up ₹16.40 (1.64%)BSE ₹1,012.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹998.40.
52-week range of traded prices to 23 Oct 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9,354 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 31 Jul 2026
- 15.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 Jul 2026
- 3.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.49%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- 21.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 Jul 2026
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,12,38541.2% delivered
Strides Pharma Science routine notices
174 filed, newest first. Page 3 of 4.
Oct 2022
21 Oct · Routine
Sep 2022
15 Sep · Routine
15 Sep · Routine
Aug 2022
19 Aug · Routine
17 Aug · Routine
2 Aug · Routine
Jul 2022
30 Jul · Routine
19 Jul · Routine
14 Jul · Routine
Jun 2022
7 Jun · Routine
May 2022
26 May · Routine
25 May · Routine
13 May · Routine
Apr 2022
Mar 2022
16 Mar · Routine
15 Mar · Routine
Feb 2022
15 Feb · Routine
3 Feb · Routine
Dec 2021
31 Dec · Routine
16 Dec · Routine
Oct 2021
28 Oct · Routine
22 Oct · Routine
Sep 2021
14 Sep · Routine
14 Sep · Routine
6 Sep · Routine
3 Sep · Routine
Aug 2021
20 Aug · Routine
13 Aug · Routine
4 Aug · Routine
Jul 2021
27 Jul · Routine
19 Jul · Routine
13 Jul · Routine
Jun 2021
25 Jun · Routine
16 Jun · Routine
May 2021
13 May · Routine
3 May · Routine
Mar 2021
5 Mar · Routine
3 Mar · Routine